R3 Vascular Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by R3 Vascular Inc.
RECRUITINGNCT04912323
Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
This first-in-human clinical feasibility study will evaluate the safety and performance of the R3 Vascular MAGNITUDE® Bioresorbable Drug-Eluting Scaffold and Delivery System in...
Sponsor: R3 Vascular Inc.Enrolling: 307 locations
Peripheral Arterial DiseaseAtherosclerotic LesionLower Extremity Ischemia+1
RECRUITINGNCT06075940
Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee...
The objective of this prospective, multi-center, clinical investigation is to evaluate the MAGNITUDE BRS System for the planned treatment of narrowed infrapopliteal lesions. Up to...
Sponsor: R3 Vascular Inc.Enrolling: 301 location
Critical Limb-Threatening IschemiaCritical Limb IschemiaCritical Lower Limb Ischemia